Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'INDEPENDENT PROSTATE-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 26 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Zogakis, TG; Libutti, SK
      General aspects of anti-angiogenesis and cancer therapy

      EXPERT OPINION ON BIOLOGICAL THERAPY
    2. Kruger, EA; Figg, WD
      Protein binding alters the activity of suramin, carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay

      CLINICAL CANCER RESEARCH
    3. Saika, T; Kusaka, N; Tsushima, T; Yamato, T; Ohashi, T; Suyama, B; Arata, R; Nasu, Y; Kumon, H
      Treatment of androgen-independent prostate cancer with dexamethasone: A prospective study in stage D2 patients

      INTERNATIONAL JOURNAL OF UROLOGY
    4. Buchanan, G; Yang, MO; Harris, JM; Nahm, HS; Han, GZ; Moore, N; Bentel, JM; Matusik, RJ; Horsfall, DJ; Marshall, VR; Greenberg, NM; Tilley, WD
      Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function

      MOLECULAR ENDOCRINOLOGY
    5. Schally, AV; Comaru-Schally, AM; Nagy, A; Kovacs, M; Szepeshazi, K; Plonowski, A; Varga, JL; Halmos, G
      Hypothalamic hormones and cancer

      FRONTIERS IN NEUROENDOCRINOLOGY
    6. Plonowski, A; Schally, AV; Koppan, M; Nagy, A; Arencibia, JM; Csernus, B; Halmos, G
      Inhibition of the UCI-107 human ovarian carcinoma cell line by a targeted cytotoxic analog of somatostatin, AN-238

      CANCER
    7. Culine, S; Droz, JP
      Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: Adecade of progress?

      ANNALS OF ONCOLOGY
    8. Grundker, C
      Cytotoxic luteinizing hormone-releasing hormone conjugates and their use in gynecological cancer therapy

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    9. Walther, MM; Rehak, NN; Venzon, D; Myers, CE; Linehan, WM; Figg, WD
      Suramin administration is associated with a decrease in serum calcium levels

      WORLD JOURNAL OF UROLOGY
    10. Plonowski, A; Schally, AV; Varga, JL; Rekasi, Z; Hebert, F; Halmos, G; Groot, K
      Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways

      PROSTATE
    11. Mendelsohn, LG
      Prostate cancer and the androgen receptor: Strategies for the development of novel therapeutics

      PROGRESS IN DRUG RESEARCH, VOL 55
    12. Amato, RJ; Bui, C; Logothetis, CJ
      Estramustine in combination with vinblastine and mitomycin-C for patients with progressive androgen independent adenocarcinoma of the prostate

      PROSTATE CANCER AND PROSTATIC DISEASES
    13. Glode, LM; Petrylak, DP
      Refractory disease, new horizons and patient-physician relationships

      PROSTATE CANCER AND PROSTATIC DISEASES
    14. van Brussel, JP; van Steenbrugge, GJ; Romijn, JC; Schroder, FH; Mickisch, GHJ
      Chemosensitivity of prostate cancer cell lines and expression of multidrugresistance-related proteins

      EUROPEAN JOURNAL OF CANCER
    15. Prendergast, GC
      Mechanisms of apoptosis by c-Myc

      ONCOGENE
    16. Abdiu, A; Larsson, SE; Wasteson, A; Walz, TM
      Suramin blocks growth-stimulatory effects of platelet-derived growth factor on malignant fibrous histiocytomas in vitro

      CANCER LETTERS
    17. Russell, PJ; Bennett, S; Joshua, A; Yu, Y; Dowing, SR; Hill, MA; Kingsley, EA; Mason, RS; Berry, J
      Elevated expression of FGF-2 does not cause prostate cancer progression inLNCaP cells

      PROSTATE
    18. Wang, JD; Takahara, S; Nonomura, N; Ichimaru, N; Toki, K; Azuma, H; Matsumiya, K; Okuyama, A; Suzuki, S
      Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation

      PROSTATE
    19. Kamradt, JM; Pienta, KJ
      Current chemotherapy regimens - What oncologists are using

      UROLOGIC CLINICS OF NORTH AMERICA
    20. Horti, J; Dixon, SC; Logothetis, CJ; Guo, Y; Reed, E; Figg, WD
      Increased transcriptional activity of prostate-specific antigen in the presence of TNP-470, an angiogenesis inhibitor

      BRITISH JOURNAL OF CANCER
    21. LAMHARZI N; HALMOS G; JUNGWIRTH A; SCHALLY AV
      DECREASE IN THE LEVEL AND MESSENGER-RNA EXPRESSION OF LH-RH AND EGF RECEPTORS AFTER TREATMENT WITH LH-RH ANTAGONIST CETRORELIX IN DU-145 PROSTATE TUMOR XENOGRAFTS IN NUDE-MICE

      International journal of oncology
    22. CAROLLO M; PARENTE L; DALESSANDRO N
      DEXAMETHASONE-INDUCED CYTOTOXIC ACTIVITY AND DRUG-RESISTANCE EFFECTS IN ANDROGEN-INDEPENDENT PROSTATE TUMOR PC-3 CELLS ARE MEDIATED BY LIPOCORTIN 1

      Oncology research
    23. HAMANN LG; HIGUCHI RI; ZHI L; EDWARDS JP; WANG XN; MARSCHKE KB; KONG JW; FARMER LJ; JONES TK
      SYNTHESIS AND BIOLOGICAL-ACTIVITY OF A NOVEL SERIES OF NONSTEROIDAL, PERIPHERALLY SELECTIVE ANDROGEN RECEPTOR ANTAGONISTS DERIVED FROM 1,2-DIHYDROPYRIDONO[5,6-G] QUINOLINES

      Journal of medicinal chemistry
    24. JUNGWIRTH A; PINSKI J; GALVAN G; HALMOS G; SZEPESHAZI K; CAI RZ; GROOT K; VADILLOBUENFIL M; SCHALLY AV
      INHIBITION OF GROWTH OF ANDROGEN-INDEPENDENT DU-145 PROSTATE-CANCER IN-VIVO BY LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST CETRORELIX AND BOMBESIN ANTAGONISTS RC-3940-II AND RC-3950-II

      European journal of cancer
    25. SIEGSMUND MJ; STEIDLER A; KREUKLER C; KOHRMANN KU; ALKEN P
      ENHANCED IN-VITRO CYTOTOXICITY OF IDARUBICIN COMPARED TO EPIRUBICIN AND DOXORUBICIN IN RAT PROSTATE CARCINOMA-CELLS

      European urology
    26. CHAUDHRY V; EISENBERGER MA; SINIBALDI VJ; SHEIKH K; GRIFFIN JW; CORNBLATH DR
      A PROSPECTIVE-STUDY OF SURAMIN-INDUCED PERIPHERAL NEUROPATHY

      Brain


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 12:35:08